Back

Norton Healthcare

  • Cannabinoid Hyperemesis Syndrome

2027 Updates in Pediatrics: Evidence-Based Care for Cannabinoid Hyperemesis Syndrome

Review the background and pathophysiology of cannabinoid hyperemesis syndrome (CHS). Explore the diagnostic approach to pediatric patients with suspected CHS. Discuss evidence-based management principles for pediatric patients with CHS. Highlight the above through the lens of clinical care guidelines for CHS developed at Norton Children’s.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1 credit

MOC types

ABP — Lifelong Learning and Self-AssessmentUp to 1 point

FDA REMS

No

Qualifies for MIPS

No
Start Date
January 20, 2027
End Date
January 21, 2027

Pricing

Free

Reported to ACCME by the provider

  • Live
  • Credit · Up to 1 credit
  • MOC · Up to 1 point
  • When
    Jan 20, 2027